Clinical Trial Update: Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants [Phase 1]

View source ↗

Summary

A Phase 1 study of the 7-valent pneumococcal conjugate vaccine (Prevnar) in healthy infants has completed, with results posted in 2009. The sponsor Wyeth is now…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• Prevnar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Pneumococcal Infections | Phase 1 | Status: COMPLETED | Results posted: 2009-05-27